Navigation Links
For the Treatment of Rheumatoid Arthritis, Market Share for TNF-alpha Inhibitors Will Decrease Through 2018
Date:5/18/2009

Actemra/RoActemra Will Emerge as the Preferred Biological Drug for TNF-Refractory Patients, According to a New Report from Decision Resources

WALTHAM, Mass., May 18 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, in the treatment of rheumatoid arthritis, the market share for TNF-alpha inhibitors will decrease to 63 percent through 2018 as a result of the increasing use of alternative agents to treat the disease. In 2008, TNF-alpha inhibitors such as Amgen/Wyeth/Takeda's Enbrel and Abbott/Eisai's Humira accounted for 80 percent of rheumatoid arthritis drug sales in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

The new Pharmacor report entitled Rheumatoid Arthritis finds that alternative biologics such as Roche/Chugai's Actemra/RoActemra will take market share away from the TNF-alpha inhibitors as interviewed rheumatologists indicate they switch to one of these agents for patients who respond inadequately to two TNF-alpha inhibitors. Actemra/RoActemra will likely emerge as the preferred agent for TNF-refractory patients and is forecasted to achieve sales of nearly $2 billion in 2018.

The report also finds that Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe/Janssen's Simponi has advantages in its drug delivery and efficacy and is expected to take significant market share away from Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe's Remicade. Simponi will also experience greater uptake than UCB/Otsuka's Cimzia, which has launched for the indication following its recent approval for rheumatoid arthritis by the Food and Drug Administration. Additionally, an emerging agent from Pfizer is expected to impact overall sales of biologics in the market.

"We expect Pfizer's CP-690550, which is in Phase III of development, to steal patient share from the
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Here to Help(TM): Unique Program Combines Direct Personal Assistance With Web-Based Resources to Improve Opioid Dependence Treatment Outcomes
2. Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise
3. Sodium channel blocker shows promise as a potential treatment for cystic fibrosis
4. The future of personalized cancer treatment: An entirely new direction for RNAi delivery
5. An Aid to Tailoring Prostate Cancer Treatment
6. Fewer Than One Percent of Infertile Couples Who Need Treatment Receive It - Website to Bridge Gap Between Infertile Couples and Fertility Clinics
7. Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18
8. Mayo Clinic researchers say agent provides treatment option for women with hot flashes
9. Can New Surgery Revolutionize Diabetes Treatment?
10. Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment
11. New Cancer Treatment Achieves First Mesothelioma Success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 Carnegie Science ... today announced a new partnership to develop BodyTech, a ... region. The initiative includes a new exhibit at the ... demonstration theater, and a new traveling science show, Anatomy ... of 2015. , Designed to explore a wide ...
(Date:5/22/2015)... May 22, 2015 Power Systems is proud ... the 2015 race season. Drobeck is in his second year ... a firefighter with the Missoula Fire Department in Missoula, MT. ... Pro in 2014. During his career, he has had 15 ... Drobeck recorded top 10 finishes in all seven of his ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 The ... Plaza Dental announces that they are now offering ... and other dental treatments. At consultations, patients can ... Questions regarding what certain treatments can achieve and ... covered during this initial appointment. If treatments are ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 A ... at the American Society of Clinical Oncology (ASCO)’s ... improved survival rates for those patients who received ... regimen of pemetrexed/cisplatin. Bevacizumab (Avastin® Genentech, Inc.) is ... and it is already routinely used to treat ...
(Date:5/22/2015)... AZ (PRWEB) May 22, 2015 In ... Olympics, Parker and Sons is offering to donate $5 ... installing an AC unit or water softening system. Customers ... behalf; Parker and Sons gets business; and the Special ... , The Special Olympics helps over 4.4 million athletes, ...
Breaking Medicine News(10 mins):Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2
... Calif., April 18 Accenx Technologies, Inc., a,leading ... care data integration solutions, announces today R. Scott ... & Marketing., Mr. Harper is a results-driven ... in establishing strong sales organizations,working in unison with ...
... Charity Event to Benefit Sharp Rehabilitation Services -, ... Diego Business Clubs,America will hold its second annual ... Barnes Tennis Center in Point Loma on June ... recreational athletes from throughout California are,expected to participate. ...
... the 21st Congress of the European College of Neuropsychopharmacology ... Congress is the largest annual meeting on psychopharmacology and ... attended by more than 6,000 participants (clinical and basic ... from all over the world. , This years ...
... INDIANAPOLIS, April 18 WellPoint, Inc. (NYSE:,WLP) today announced ... its,State Sponsored Business division, effective April 21, 2008., ... leading WellPoint,s,Medicaid business division which currently serves more than ... fortunate to add the quality of experience and,expertise that ...
... illness doesn,t ease the problem, experts say , , FRIDAY, April ... is only connected to other conditions is hampering the development ... , It,s one of two studies on chronic cough published ... papers are by the same authors: Kian Fan Chung of ...
... in Centers for Comprehensive Women,s Care program, ... has designated Baptist Memorial Hospital for Women as ... Care (CCWC) program., The CCWC program recognizes ... health care with a focus on quality and,patient-centered ...
Cached Medicine News:Health News:Accenx Technologies Announces New Leadership in Sales and Marketing Division 2Health News:21st Congress of the College of Neuropsychopharmacology 2Health News:WellPoint Appoints Kevin R. Hayden as President of State Sponsored Business 2Health News:Health Woes Not Always to Blame for Chronic Cough 2Health News:BlueCross Recognizes Baptist Women's Hospital 2
(Date:5/22/2015)... 2015 /CNW/ - The Taskforce representing Canada,s ... the hard work that the Minister and Health Canada have ... program recognizes the needs of the thalidomide survivors, and more ... year, tax free, with annual adjustments for inflation. ... payments of $100,000 based on the severity of their disability, ...
(Date:5/22/2015)... More than fifty years ago, Thalidomide was approved by Health ... Tragically, Thalidomide caused serious and permanent physical and emotional damage ... been provided to survivors over the years from sources including ... in 1991 and settlements from drug companies. ... support, we have a clear moral obligation to help meet ...
(Date:5/22/2015)... 2015 The Assistance Fund announces the addition ... financial assistance for copay to individuals diagnosed with Melanoma. ... addition of the Melanoma Copay Assistance Program to our ... executive director. "With each additional program we are closer ... where no one is denied access to medications due ...
Breaking Medicine Technology:Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3The Assistance Fund Adds Melanoma Assistance Program 2
... 5, 2011 Watson Pharmaceuticals, Inc. (NYSE: WPI ... the Company intends to release its first quarter 2011 financial ... of the U.S. financial markets.  The Company will also host ... on April 27, 2011 to discuss its financial results and ...
... more than $226 million to Arizona,s economy in 2010, ... by a university professor. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO ... to state economic development officials and legislators, showed that ... in the state. The analysis was conducted ...
Cached Medicine Technology:Watson to Host Conference Call and Webcast to Discuss First Quarter 2011 Earnings 2Express Scripts Injects $226 Million Into Arizona Economy, Study Finds 2
... sized High-Throughput Submarine Systems are designed ... from microtitre plates. Analyze high numbers ... oligos or PCR products simultaneously. The ... accuracy and speed with additional savings ...
... Dodeca cell runs up to 12 mini ... minutes. Handcast gels can be poured 12 ... 485 gradient former and Mini-PROTEAN 3 multi-casting ... reproducibility. Alternatively, Ready Gel precast gels offer ...
... Criterion Dodeca cell, a component of the Criterion ... to 12 Criterion gels in a single run. ... 8.7 cm) than the traditional mini gel. They ... give you the optimal combination of separation and ...
... runs up to 12 mini gels under ... gels can be poured 12 at a ... former and Mini-PROTEAN 3 multi-casting chamber, eliminating ... Ready Gel precast gels offer the convenience ...
Medicine Products: